Patient has an infection requiring treatment with systemic antibiotics or antiviral medication or has completed treatment for such an infection within  days prior to planned first dose of study drug
Active infection requiring within  weeks prior to first dose of study drug
Subject has an uncontrolled active infection requiring treatment and fever .C or higher  hours before the first dose of study drug. Controlled infections (i.e.  negative cultures completing antibiotics and/or stable fungal infection in therapy) are allowed provided the subject has a temperature of < .C within  hours of the first dose of study drug.
If they have a major systemic infection requiring antibiotics  hours or less prior to the first dose of study drug
Serious, systemic infection requiring treatment ?  days before the first dose of study drug
Serious, systemic infection requiring treatment =<  days before the first dose of study drug
Active infection requiring antibiotics or antifungals within  days prior to first dose of study drug
Major systemic infection requiring antibiotics  hours or less prior to first dose of study drug
Patients must not have an active major systemic infection requiring systemic antibiotics  hours or less prior to the first dose of study drug
If they have a major systemic infection requiring antibiotics  hours or less prior to the first dose of study drug
Subject has an uncontrolled active infection requiring treatment and fever .C or higher  hours before the first dose of study drug. Controlled infections (i.e.  negative cultures completing antibiotics and/or stable fungal infection in therapy are allowed provided the subject has a temperature of <.C within  hours of the first dose of study drug
Active infection requiring antibiotics or antifungals within  days prior to first dose of study drug
Active infection requiring treatment ?  days before first dose of study drug
Evidence of active infection within  weeks prior to first dose of study treatment.
Active infection requiring antibiotics or antifungals within  days prior to first dose of study drug
Active infection requiring treatment ? days before the first dose of study drug
Evidence of active viral, bacterial, or systemic fungal infection requiring systemic treatment within  days prior to the first dose of study drug. Patients requiring any systemic antiviral, antifungal, or antibacterial therapy for active infection must have completed treatment no less than  days prior to the first dose of study drug.
Subject has evidence of an active infection requiring systemic therapy within  days prior to the planned first dose of study drug.
Subject has evidence of active infection requiring systemic therapy within  days prior to the first dose of study drug.
Patient with an infection requiring treatment with systemic antibiotics or antiviral medication or has completed treatment for such an infection within  days prior to planned initial dose of WT.
Patient has an infection and has had a body temperature of > .?C within  hours prior to planned first dose of study drug.
Serious infection within  days before the first dose of study drug. Participant must have recovered from infection before first dose.
Uncontrolled infection requiring systematic antibiotics within  days before the first dose of study drug
Active infection requiring within  weeks prior to first dose of study drug
